rs2239316

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004380.3(CREBBP):​c.86-12985T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.326 in 152,032 control chromosomes in the GnomAD database, including 8,744 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 8744 hom., cov: 32)

Consequence

CREBBP
NM_004380.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.343

Publications

18 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CREBBPNM_004380.3 linkc.86-12985T>C intron_variant Intron 1 of 30 ENST00000262367.10 NP_004371.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CREBBPENST00000262367.10 linkc.86-12985T>C intron_variant Intron 1 of 30 1 NM_004380.3 ENSP00000262367.5 Q92793-1
CREBBPENST00000382070.7 linkc.86-12985T>C intron_variant Intron 1 of 29 1 ENSP00000371502.3 Q92793-2

Frequencies

GnomAD3 genomes
AF:
0.326
AC:
49512
AN:
151914
Hom.:
8726
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.443
Gnomad AMI
AF:
0.195
Gnomad AMR
AF:
0.303
Gnomad ASJ
AF:
0.232
Gnomad EAS
AF:
0.344
Gnomad SAS
AF:
0.447
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.261
Gnomad NFE
AF:
0.263
Gnomad OTH
AF:
0.313
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.326
AC:
49570
AN:
152032
Hom.:
8744
Cov.:
32
AF XY:
0.328
AC XY:
24407
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.444
AC:
18408
AN:
41464
American (AMR)
AF:
0.303
AC:
4625
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.232
AC:
804
AN:
3468
East Asian (EAS)
AF:
0.344
AC:
1778
AN:
5172
South Asian (SAS)
AF:
0.444
AC:
2139
AN:
4816
European-Finnish (FIN)
AF:
0.289
AC:
3057
AN:
10574
Middle Eastern (MID)
AF:
0.250
AC:
73
AN:
292
European-Non Finnish (NFE)
AF:
0.263
AC:
17845
AN:
67950
Other (OTH)
AF:
0.315
AC:
664
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1689
3379
5068
6758
8447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.281
Hom.:
26911
Bravo
AF:
0.331
Asia WGS
AF:
0.425
AC:
1476
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.7
DANN
Benign
0.69
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239316; hg19: chr16-3913995; API